Preclinical evaluation of dual-labeled PSMA-inhibitors for the diagnosis and therapy of prostate cancer

被引：0
|
作者：
Baranski, Ann-Christin [3 ]
Schaefer, Martin [3 ]
Bauder-Wuest, Ulrike [3 ]
Roscher, Mareike [3 ]
Schmidt, Jana [3 ]
Stenau, Esther [2 ]
Simpfendoerfer, Tobias [5 ]
Maier-Hein, Lena [2 ]
Hadaschik, Boris [5 ]
Haberkorn, Uwe [1 ,4 ]
Eder, Matthias [1 ]
Kopka, Klaus [3 ]
机构：
[1] German Canc Res Ctr, Clin Cooperat Unit, Nucl Med, Heidelberg, Germany
[2] German Canc Res Ctr, Div Comp Assisted Med Intervent, Heidelberg, Germany
[3] German Canc Res Ctr, Div Radiopharmaceut Chem, Heidelberg, Germany
[4] Univ Hosp, Dept Nucl Med, Heidelberg, Germany
[5] Univ Hosp, Dept Urol, Heidelberg, Germany
来源：
JOURNAL OF NUCLEAR MEDICINE | 2017年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
531
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Preclinical characterization of a dual-labeled trastuzumab-based imaging agent for diagnosing advanced gastric cancer
    Wang, Xuejuan
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [22] Auger electron therapy of prostate cancer: a preclinical evaluation of 58mCo-DOTA-PSMA-617
    Baun, C.
    Dam, J. H.
    Ewald, J. D.
    Kristensen, B. W.
    Laursen, V. S.
    Hildebrandt, M. G.
    Olsen, B. B.
    Thisgaard, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S339 - S339
  • [23] Preparation and preclinical evaluation of 64Cu-labeled prostate-specific membrane antigen (PSMA) probe for PET imaging of prostate cancer
    Okarvi, Subhani
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [24] A Preclinical Study of an 125I-Labeled PSMA Ligand for Prostate-Cancer Puncture
    Luan, Xiaohui
    Zhou, Haoxi
    Chen, Yimin
    Zhang, Xiaojun
    Cui, Mengchao
    Chen, Kuang
    Xu, Xiaodan
    Zhang, Jinming
    Xu, Baixuan
    PHARMACEUTICALS, 2022, 15 (10)
  • [25] PSMA-Targeted Radiopharmaceuticals for Prostate Cancer Diagnosis and Therapy
    Oldan, Jorge D.
    Almaguel, Frankis
    Voter, Andrew F.
    Duran, Alfonso
    Gafita, Andrei
    Pomper, Martin G.
    Hope, Thomas A.
    Rowe, Steven P.
    CANCER JOURNAL, 2024, 30 (03): : 176 - 184
  • [26] Prostate specific membrane antigen (PSMA) ligands for diagnosis and therapy of prostate cancer
    Barrio, Martin
    Fendler, Wolfgang P.
    Czernin, Johannes
    Herrmann, Ken
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2016, 16 (11) : 1177 - 1188
  • [27] A preclinical evaluation of 89Zr-labeled PSMA ligands for pre-treatment dosimetry for 177Lu-labeled PSMA therapy
    Prive, B.
    Derks, Y. H. W.
    Franssen, G. M.
    Peters, S. M. B.
    Konijnenberg, M. W.
    Gotthardt, M.
    Janssen, M. J. R.
    Laverman, P.
    Nagarajah, J.
    Heskamp, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S374 - S375
  • [28] [99mTc]TRICARBONYL-LABELED PSMA INHIBITORS FOR PROSTATE CANCER IMAGING
    Banerjee, S. R.
    Pullambhatla, M.
    Byun, Y.
    Fox, J. J.
    Mease, R. C.
    Pomper, M. G.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2009, 52 : S48 - S48
  • [29] High Affinity F-18 Labeled PSMA Inhibitors: Preclinical Evaluation and Comparison to 68GaDKFZ-PSMA-11
    Kelly, J. M.
    Amor-Coarasa, A.
    Nikolopoulou, A.
    Kim, D.
    Williams, C., Jr.
    Ponnala, S.
    Babich, J. W.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S13 - S14
  • [30] Relaxation properties of a dual-labeled probe for MRI and neutron capture therapy
    Tatham, AT
    Nakamura, H
    Wiener, EC
    Yamamoto, Y
    MAGNETIC RESONANCE IN MEDICINE, 1999, 42 (01) : 32 - 36
12345